Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_assertion type Assertion NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_head.
- NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_provenance.
- NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_assertion evidence source_evidence_literature NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_provenance.
- NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_assertion SIO_000772 12738753 NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_provenance.
- NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_assertion wasDerivedFrom befree-20150227 NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_provenance.
- NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_assertion wasGeneratedBy ECO_0000203 NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_provenance.